phosphatidylcholines has been researched along with ct 2584 in 2 studies
Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (ct 2584) | Trials (ct 2584) | Recent Studies (post-2010) (ct 2584) |
---|---|---|---|---|---|
32,204 | 443 | 5,593 | 8 | 2 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bursten, S; Finney, RE; Klein, P; Leer, LL; Lewis, RA; Nudelman, E; Singer, JW; Waggoner, D; Wang, N; White, T | 1 |
Bonfil, RD | 1 |
2 other study(ies) available for phosphatidylcholines and ct 2584
Article | Year |
---|---|
Pharmacological inhibition of phosphatidylcholine biosynthesis is associated with induction of phosphatidylinositol accumulation and cytolysis of neoplastic cell lines.
Topics: Adrenergic beta-Antagonists; Antineoplastic Agents; Breast Neoplasms; Cell Death; Cell Survival; Choline Kinase; Choline-Phosphate Cytidylyltransferase; Cytidine Diphosphate Diglycerides; Drug Synergism; Humans; Lung Neoplasms; Phosphatidic Acids; Phosphatidylcholines; Phosphatidylinositols; Propranolol; Substrate Specificity; Tumor Cells, Cultured; Xanthines | 2000 |
CT-2584 (Cell Therapeutics).
Topics: Animals; Antineoplastic Agents; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Evaluation, Preclinical; Drugs, Investigational; Enzyme Inhibitors; Fatigue; Hematuria; Humans; Male; Molecular Structure; Phosphatidic Acids; Phosphatidylcholines; Phospholipase D; Prostatic Neoplasms; Sarcoma; Tumor Cells, Cultured; Xanthines | 2001 |